BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27875574)

  • 1. Chidamide Inhibits Aerobic Metabolism to Induce Pancreatic Cancer Cell Growth Arrest by Promoting Mcl-1 Degradation.
    He M; Qiao Z; Wang Y; Kuai Q; Li C; Wang Y; Jiang X; Wang X; Li W; He M; Ren S; Yu Q
    PLoS One; 2016; 11(11):e0166896. PubMed ID: 27875574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
    Zhao B; He T
    Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells.
    Qiao Z; Ren S; Li W; Wang X; He M; Guo Y; Sun L; He Y; Ge Y; Yu Q
    Biochem Biophys Res Commun; 2013 Apr; 434(1):95-101. PubMed ID: 23541946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chidamide-induced ROS accumulation and miR-129-3p-dependent cell cycle arrest in non-small lung cancer cells.
    Wu YF; Ou CC; Chien PJ; Chang HY; Ko JL; Wang BY
    Phytomedicine; 2019 Mar; 56():94-102. PubMed ID: 30668358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRIBB11 accelerates Mcl-1 degradation through an HSF1-independent, Mule-dependent pathway in A549 non-small cell lung cancer cells.
    Kang MJ; Yun HH; Lee JH
    Biochem Biophys Res Commun; 2017 Oct; 492(3):304-309. PubMed ID: 28859986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity.
    Ning ZQ; Li ZB; Newman MJ; Shan S; Wang XH; Pan DS; Zhang J; Dong M; Du X; Lu XP
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):901-9. PubMed ID: 22080169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 ubiquitin ligases β-TrCP and FBXW7 cooperatively mediates GSK3-dependent Mcl-1 degradation induced by the Akt inhibitor API-1, resulting in apoptosis.
    Ren H; Koo J; Guan B; Yue P; Deng X; Chen M; Khuri FR; Sun SY
    Mol Cancer; 2013 Nov; 12():146. PubMed ID: 24261825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK5 Inhibitor Downregulates Mcl-1 and Sensitizes Pancreatic Cancer Cell Lines to Navitoclax.
    Kour S; Rana S; Contreras JI; King HM; Robb CM; Sonawane YA; Bendjennat M; Crawford AJ; Barger CJ; Kizhake S; Luo X; Hollingsworth MA; Natarajan A
    Mol Pharmacol; 2019 Oct; 96(4):419-429. PubMed ID: 31467029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renieramycin T Induces Lung Cancer Cell Apoptosis by Targeting Mcl-1 Degradation: A New Insight in the Mechanism of Action.
    Petsri K; Chamni S; Suwanborirux K; Saito N; Chanvorachote P
    Mar Drugs; 2019 May; 17(5):. PubMed ID: 31117253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effect of chidamide on the growth of human adenoid cystic carcinoma cells.
    Yang S; Nan P; Li C; Lin F; Li H; Wang T; Zhou C; Zhang X; Meng X; Qian H; Wang H; Dong M
    Biomed Pharmacother; 2018 Mar; 99():608-614. PubMed ID: 29710459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel histone deacetylase inhibitor Chidamide induces G0/G1 arrest and apoptosis in myelodysplastic syndromes.
    Liu Z; Ding K; Li L; Liu H; Wang Y; Liu C; Fu R
    Biomed Pharmacother; 2016 Oct; 83():1032-1037. PubMed ID: 27541047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation of Mcl-1 through GSK-3β Activation Regulates Apoptosis Induced by Bufalin in Non-Small Cell Lung Cancer H1975 Cells.
    Kang XH; Zhang JH; Zhang QQ; Cui YH; Wang Y; Kou WZ; Miao ZH; Lu P; Wang LF; Xu ZY; Cao F
    Cell Physiol Biochem; 2017; 41(5):2067-2076. PubMed ID: 28419994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of chidamide on human B lymphoma cell lines and its mechanisms].
    Li YY; Wang YF; Wang J; Ke XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):893-9. PubMed ID: 22931650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganoderma immunomodulatory protein and chidamide down-regulate integrin-related signaling pathway result in migration inhibition and apoptosis induction.
    Lu CT; Leong PY; Hou TY; Huang SJ; Hsiao YP; Ko JL
    Phytomedicine; 2018 Dec; 51():39-47. PubMed ID: 30466626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of mitochondrial oxidative phosphorylation by chidamide eradicates leukemic cells in AML.
    Wang JD; Xu JQ; Long ZJ; Weng JY
    Clin Transl Oncol; 2023 Jun; 25(6):1805-1820. PubMed ID: 36899123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trametinib potentiates TRAIL-induced apoptosis via FBW7-dependent Mcl-1 degradation in colorectal cancer cells.
    Lin L; Ding D; Xiao X; Li B; Cao P; Li S
    J Cell Mol Med; 2020 Jun; 24(12):6822-6832. PubMed ID: 32352219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTOR Complex 2 Stabilizes Mcl-1 Protein by Suppressing Its Glycogen Synthase Kinase 3-Dependent and SCF-FBXW7-Mediated Degradation.
    Koo J; Yue P; Deng X; Khuri FR; Sun SY
    Mol Cell Biol; 2015 Jul; 35(13):2344-55. PubMed ID: 25918246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of Chidamide in hepatocellular carcinoma cell lines.
    Wang H; Guo Y; Fu M; Liang X; Zhang X; Wang R; Lin C; Qian H
    Mol Med Rep; 2012 Jun; 5(6):1503-8. PubMed ID: 22484326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noxa/Mcl-1 balance influences the effect of the proteasome inhibitor MG-132 in combination with anticancer agents in pancreatic cancer cell lines.
    Naumann K; Schmich K; Jaeger C; Kratz F; Merfort I
    Anticancer Drugs; 2012 Jul; 23(6):614-26. PubMed ID: 22314265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.